Diversified Healthcare Trust (DHC) EBITDA Margin (2009 - 2026)

Diversified Healthcare Trust (DHC) has reported EBITDA Margin for 18 consecutive years, with 1.28% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA Margin rose 1213.0% year-over-year to 1.28%; the trailing twelve-month figure through Jun 2026 stood at 11.52% (up 212.0% YoY), and the FY2025 full-year result was 16.98%, down 630.0% from the prior year.
• EBITDA Margin climbed to 1.28% in Q2 2026 per DHC's latest filing, from 3.55% in the prior quarter.
• Across five years, EBITDA Margin topped out at 113.58% in Q1 2022 and bottomed at 32.1% in Q3 2025.
• Historically, EBITDA Margin has averaged 4.37% across 5 years, with a median of 2.42% in 2026.
• The widest YoY moves for EBITDA Margin: up 9696 bps in 2022, down 13341 bps in 2022.
• Over 5 years, EBITDA Margin stood at 14.8% in 2022, then retreated by 2 bps to 14.55% in 2023, then slumped by 189 bps to 12.9% in 2024, then soared by 38 bps to 7.99% in 2025, then jumped by 84 bps to 1.28% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 1.28%, 3.55%, and 7.99% for Q2 2026, Q1 2026, and Q4 2025 respectively.